- Home
- CCCC vs AKA Comparison
CCCC vs AKA Comparison
Compare CCCC & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- AKA
- Stock Information
- Founded
- CCCC 2015
- AKA 2018
- Country
- CCCC United States
- AKA United States
- Employees
- CCCC N/A
- AKA N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- AKA Catalog/Specialty Distribution
- Sector
- CCCC Health Care
- AKA Consumer Discretionary
- Exchange
- CCCC Nasdaq
- AKA Nasdaq
- Market Cap
- CCCC 104.4M
- AKA 120.0M
- IPO Year
- CCCC 2020
- AKA 2021
- Fundamental
- Price
- CCCC $1.54
- AKA $12.14
- Analyst Decision
- CCCC Buy
- AKA Buy
- Analyst Count
- CCCC 3
- AKA 4
- Target Price
- CCCC $12.00
- AKA $22.50
- AVG Volume (30 Days)
- CCCC 995.5K
- AKA 6.7K
- Earning Date
- CCCC 07-31-2025
- AKA 08-06-2025
- Dividend Yield
- CCCC N/A
- AKA N/A
- EPS Growth
- CCCC N/A
- AKA N/A
- EPS
- CCCC N/A
- AKA N/A
- Revenue
- CCCC $39,783,000.00
- AKA $586,514,000.00
- Revenue This Year
- CCCC N/A
- AKA $6.60
- Revenue Next Year
- CCCC N/A
- AKA $4.14
- P/E Ratio
- CCCC N/A
- AKA N/A
- Revenue Growth
- CCCC 98.56
- AKA 8.09
- 52 Week Low
- CCCC $1.09
- AKA $7.00
- 52 Week High
- CCCC $7.66
- AKA $32.25
- Technical
- Relative Strength Index (RSI)
- CCCC 50.55
- AKA 50.98
- Support Level
- CCCC $1.36
- AKA $10.25
- Resistance Level
- CCCC $1.63
- AKA $12.91
- Average True Range (ATR)
- CCCC 0.14
- AKA 0.72
- MACD
- CCCC -0.00
- AKA -0.21
- Stochastic Oscillator
- CCCC 38.33
- AKA 53.11
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.